Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangiosarcoma × Disulfides × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 25 Ovarian Neoplasms 23 Fallopian Tube Neoplasms 21 Carcinoma, Non-Small-Cell Lung 20 Colorectal Neoplasms 14 Glioblastoma 10 Pancreatic Neoplasms 9 Carcinoma, Renal Cell 9 Melanoma 8 Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Carcinoma, Hepatocellular 7 Brenner Tumor 7 Urinary Bladder Neoplasms 6 Mycosis Fungoides 6 Lymphoma, Large B-Cell, Diffuse 6 Brain Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Colonic Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Sezary Syndrome 4 Sarcoma 4 Rectal Neoplasms 4 Multiple Myeloma 4 Gliosarcoma 4 Urethral Neoplasms 3

Interventions

Doxorubicin 16 Ifosfamide 10 pazopanib 6 Radiotherapy 6 Paclitaxel 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Docetaxel 3 trebananib 2 cixutumumab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Watchful Waiting 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Conformal 2 Magnetic Resonance Spectroscopy 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡